These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 34735656)

  • 1. Is Myelodysplasia a Consequence of Normal Aging?
    Heibl S; Stauder R; Pfeilstöcker M
    Curr Oncol Rep; 2021 Nov; 23(12):142. PubMed ID: 34735656
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aging, hematopoiesis, and the myelodysplastic syndromes.
    Chung SS; Park CY
    Hematology Am Soc Hematol Educ Program; 2017 Dec; 2017(1):73-78. PubMed ID: 29222239
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Uncovering perturbations in human hematopoiesis associated with healthy aging and myeloid malignancies at single-cell resolution.
    Ainciburu M; Ezponda T; Berastegui N; Alfonso-Pierola A; Vilas-Zornoza A; San Martin-Uriz P; Alignani D; Lamo-Espinosa J; San-Julian M; Jiménez-Solas T; Lopez F; Muntion S; Sanchez-Guijo F; Molero A; Montoro J; Serrano G; Diaz-Mazkiaran A; Lasaga M; Gomez-Cabrero D; Diez-Campelo M; Valcarcel D; Hernaez M; Romero JP; Prosper F
    Elife; 2023 Jan; 12():. PubMed ID: 36629404
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular mechanism of microRNA involvement in genesis of myelodysplastic syndrome and its transformation to acute myeloid leukemia.
    Liao R; Xu Y; Chen M; Chen X; Zhan X; Sun J
    Hematology; 2013 Jul; 18(4):191-7. PubMed ID: 23321417
    [TBL] [Abstract][Full Text] [Related]  

  • 5. What is the role of the microenvironment in MDS?
    Calvi LM; Li AJ; Becker MW
    Best Pract Res Clin Haematol; 2019 Dec; 32(4):101113. PubMed ID: 31779976
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mesenchymal Stem and Progenitor Cells in Normal and Dysplastic Hematopoiesis-Masters of Survival and Clonality?
    Pleyer L; Valent P; Greil R
    Int J Mol Sci; 2016 Jun; 17(7):. PubMed ID: 27355944
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Myelodysplasia: differentiating neoplastic from nonneoplastic syndromes of ineffective hematopoiesis in dogs.
    Blue JT
    Toxicol Pathol; 2003; 31 Suppl():44-8. PubMed ID: 12597430
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oncogenic
    Osswald L; Hamarsheh S; Uhl FM; Andrieux G; Klein C; Dierks C; Duquesne S; Braun LM; Schmitt-Graeff A; Duyster J; Boerries M; Brummer T; Zeiser R
    Mol Cancer Res; 2021 Sep; 19(9):1596-1608. PubMed ID: 34088868
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MDS-like experimental myelodysplasia: multilineage abnormal hematopoiesis in transgenic mice harboring the SV40 large T antigen under an immunoglobulin enhancer.
    Furuta Y; Aizawa S; Suda Y; Ikawa Y; Nishikawa S; Hayashi S; Hirabayashi Y; Inoue T
    Exp Hematol; 1993 Jun; 21(6):806-15. PubMed ID: 8500578
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Myelodysplastic syndromes].
    Giagounidis A
    Internist (Berl); 2013 Jun; 54(6):699-708. PubMed ID: 23657619
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phenotypic characterization of aberrant stem and progenitor cell populations in myelodysplastic syndromes.
    Ostendorf BN; Flenner E; Flörcken A; Westermann J
    PLoS One; 2018; 13(5):e0197823. PubMed ID: 29799854
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Involvement and functional impairment of the CD34(+)CD38(-)Thy-1(+) hematopoietic stem cell pool in myelodysplastic syndromes with trisomy 8.
    Nilsson L; Astrand-Grundström I; Anderson K; Arvidsson I; Hokland P; Bryder D; Kjeldsen L; Johansson B; Hellström-Lindberg E; Hast R; Jacobsen SE
    Blood; 2002 Jul; 100(1):259-67. PubMed ID: 12070035
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inappropriate Notch activity and limited mesenchymal stem cell plasticity in the bone marrow of patients with myelodysplastic syndromes.
    Varga G; Kiss J; Várkonyi J; Vas V; Farkas P; Pálóczi K; Uher F
    Pathol Oncol Res; 2007; 13(4):311-9. PubMed ID: 18158566
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization and targeting of malignant stem cells in patients with advanced myelodysplastic syndromes.
    Stevens BM; Khan N; D'Alessandro A; Nemkov T; Winters A; Jones CL; Zhang W; Pollyea DA; Jordan CT
    Nat Commun; 2018 Sep; 9(1):3694. PubMed ID: 30209285
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bone marrow niche in the myelodysplastic syndromes.
    Cogle CR; Saki N; Khodadi E; Li J; Shahjahani M; Azizidoost S
    Leuk Res; 2015 Oct; 39(10):1020-7. PubMed ID: 26276090
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of apoptosis by BCL2 prevents leukemic transformation of a murine myelodysplastic syndrome.
    Slape CI; Saw J; Jowett JB; Aplan PD; Strasser A; Jane SM; Curtis DJ
    Blood; 2012 Sep; 120(12):2475-83. PubMed ID: 22855610
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular pathways mediating MDS/AML with focus on AML1/RUNX1 point mutations.
    Harada Y; Harada H
    J Cell Physiol; 2009 Jul; 220(1):16-20. PubMed ID: 19334039
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clonal Hematopoiesis and therapy related MDS/AML.
    Desai P; Roboz GJ
    Best Pract Res Clin Haematol; 2019 Mar; 32(1):13-23. PubMed ID: 30927970
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of TGFβ in hematopoiesis and myeloid disorders.
    Bataller A; Montalban-Bravo G; Soltysiak KA; Garcia-Manero G
    Leukemia; 2019 May; 33(5):1076-1089. PubMed ID: 30816330
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD34+ cells from patients with myelodysplastic syndrome present different p21 dependent premature senescence.
    Xiao Y; Wang J; Song H; Zou P; Zhou D; Liu L
    Leuk Res; 2013 Mar; 37(3):333-40. PubMed ID: 23219618
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.